Cargando…
Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease
The majority of hereditary neuropathies are caused by duplication of the peripheral myelin protein 22 (PMP22) gene. Therefore, mechanisms to suppress the expression of the PMP22 gene have high therapeutic significance. Here we asked whether the human PMP22 gene is a target for regulation by microRNA...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920087/ https://www.ncbi.nlm.nih.gov/pubmed/31455873 http://dx.doi.org/10.1038/s41434-019-0098-z |
_version_ | 1783480872860647424 |
---|---|
author | Serfecz, Jacquelyn Bazick, Hannah Al Salihi, Mohammed Omar Turner, Peter Fields, Christopher Cruz, Pedro Renne, Rolf Notterpek, Lucia |
author_facet | Serfecz, Jacquelyn Bazick, Hannah Al Salihi, Mohammed Omar Turner, Peter Fields, Christopher Cruz, Pedro Renne, Rolf Notterpek, Lucia |
author_sort | Serfecz, Jacquelyn |
collection | PubMed |
description | The majority of hereditary neuropathies are caused by duplication of the peripheral myelin protein 22 (PMP22) gene. Therefore, mechanisms to suppress the expression of the PMP22 gene have high therapeutic significance. Here we asked whether the human PMP22 gene is a target for regulation by microRNA 29a (miR-29a). Using bioinformatics, we determined that the human PMP22 gene contains the conserved seed sequence of the miR-29a binding site and this regulatory motif is included in the duplicated region in neuropathic patients. Using luciferase reporter assays in HEK293 cells, we demonstrated that transient transfection of a miR-29a mimic is associated with reduction in PMP22 3′UTR reporter activity. Transfecting normal and humanized transgenic neuropathic mouse Schwann cells with a miR-29a expression plasmid effectively lowered both the endogenous mouse and the transgenic human PMP22 transcripts compared with control vector. In dermal fibroblasts derived from neuropathic patients, ectopic expression of miR-29a led to ~50% reduction in PMP22 mRNA, which corresponded to ~20% decrease in PMP22 protein levels. Significantly, miR-29a-mediated reduction in PMP22 mitigated the reduced mitotic capacity of the neuropathic cells. Together, these results support further testing of miR-29a and/or PMP22-targeting siRNAs as therapeutic agents for correcting the aberrant expression of PMP22 in neuropathic patients. |
format | Online Article Text |
id | pubmed-6920087 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69200872019-12-20 Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease Serfecz, Jacquelyn Bazick, Hannah Al Salihi, Mohammed Omar Turner, Peter Fields, Christopher Cruz, Pedro Renne, Rolf Notterpek, Lucia Gene Ther Article The majority of hereditary neuropathies are caused by duplication of the peripheral myelin protein 22 (PMP22) gene. Therefore, mechanisms to suppress the expression of the PMP22 gene have high therapeutic significance. Here we asked whether the human PMP22 gene is a target for regulation by microRNA 29a (miR-29a). Using bioinformatics, we determined that the human PMP22 gene contains the conserved seed sequence of the miR-29a binding site and this regulatory motif is included in the duplicated region in neuropathic patients. Using luciferase reporter assays in HEK293 cells, we demonstrated that transient transfection of a miR-29a mimic is associated with reduction in PMP22 3′UTR reporter activity. Transfecting normal and humanized transgenic neuropathic mouse Schwann cells with a miR-29a expression plasmid effectively lowered both the endogenous mouse and the transgenic human PMP22 transcripts compared with control vector. In dermal fibroblasts derived from neuropathic patients, ectopic expression of miR-29a led to ~50% reduction in PMP22 mRNA, which corresponded to ~20% decrease in PMP22 protein levels. Significantly, miR-29a-mediated reduction in PMP22 mitigated the reduced mitotic capacity of the neuropathic cells. Together, these results support further testing of miR-29a and/or PMP22-targeting siRNAs as therapeutic agents for correcting the aberrant expression of PMP22 in neuropathic patients. Nature Publishing Group UK 2019-08-27 2019 /pmc/articles/PMC6920087/ /pubmed/31455873 http://dx.doi.org/10.1038/s41434-019-0098-z Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Serfecz, Jacquelyn Bazick, Hannah Al Salihi, Mohammed Omar Turner, Peter Fields, Christopher Cruz, Pedro Renne, Rolf Notterpek, Lucia Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease |
title | Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease |
title_full | Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease |
title_fullStr | Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease |
title_full_unstemmed | Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease |
title_short | Downregulation of the human peripheral myelin protein 22 gene by miR-29a in cellular models of Charcot–Marie–Tooth disease |
title_sort | downregulation of the human peripheral myelin protein 22 gene by mir-29a in cellular models of charcot–marie–tooth disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920087/ https://www.ncbi.nlm.nih.gov/pubmed/31455873 http://dx.doi.org/10.1038/s41434-019-0098-z |
work_keys_str_mv | AT serfeczjacquelyn downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease AT bazickhannah downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease AT alsalihimohammedomar downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease AT turnerpeter downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease AT fieldschristopher downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease AT cruzpedro downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease AT rennerolf downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease AT notterpeklucia downregulationofthehumanperipheralmyelinprotein22genebymir29aincellularmodelsofcharcotmarietoothdisease |